Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Add to Basket
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN153114

ERK1 / ERK2 (pT-E-pY Motif) antibody

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

»Alternatives pT-E-pY Motif
»Alternatives Human
»Alternatives Rabbit
Clonality Polyclonal
»Alternatives Un-conjugated
»Alternatives Western Blotting (WB)
Pubmed 4 references available
Catalog no. ABIN153114
Quantity 0.1 mL
Contact our Customer Service for availability and price in your country.
Shipping to
Immunogen Synthetic phospholyrated peptide (KLH coupled) corresponding to residues aroundThr202/Tyr204 of human p44 MAP kinase (Erk1 and Erk2).
Specificity This antibody recognises ERK1 phosphorylated at Thr202 and ERK1 phosphorylated atTyr204.Phosphorylated:Thr202/Tyr204. Species Reactivity: Cross-reacts with Human, Mouse and Rat. Not yet tested in other species. Localization: Cell Membrane.
Cross-Reactivity Human, Mouse (Murine), Rat (Rattus)
Purification Serum
Background ERK (extracellular signal regulated kinase), also known as MAPK (mitogen activatedprotein kinase) has two closely related isoforms of 44 kDa and 42 kDa, respectively.These kinases belong to a family of serine/threonine kinases that are activated upontreatment of cells with a large variety of stimuli including mitogens, hormones, growthfactors, cytokines, and bioactive peptides. Cell stimulation induces the activation of asignaling cascade, the downstream effects of which have been linked to the regulationof cell growth and differentiation as well as the cytoskeleton. ERK1 and ERK2 arephosphorylated within the activation loop on both a Threonine and a Tyrosine residue(within a Thr-Glu-Tyr motif) by MEKs (MAPK/ERK kinases), thereby greatly elevatingthe activity of ERK1&2. Alternate Names: anti-ERT1 antibody, anti-Extracellular signal regulated kinase 1 antibody,anti-Extracellular signal regulated kinase 2 antibody, anti-MAP kinase 2 antibody,anti-MAPK 2 antibody, anti-MAPK 3 antibody, anti-Mitogen activated protein kinase 1antibody, anti-Mitogen activated protein kinase 3 antibody, anti-p42MAPK antibody,anti-p44ERK1 antibody, anti-p44MAPK antibody, anti-PRKM 1 antibody, anti-PRKM 2antibody, anti-PRKM 3 antibody, anti-Protein kinase mitogen activated 1 antibody,anti-Protein kinase mitogen activated 2 antibody, anti-Protein kinase mitogen activated 3antibody, anti-Protein tyrosine kinase ERK 2 antibody.
Gene ID 5595, 26417, 50689
Research Area Signaling, Inflammation, Phospho-specific antibodies
Application Notes Suggested working dilutions: Western Blot 1/5000. Positive Controls: NIH3T3 cell lysates stimulated with PDGF.
Restrictions For Research Use only
Format Liquid
Concentration 1 mg/ml
Buffer 50% Glycerol, PBS
Storage 4 °C
Kolch: "Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions." in: The Biochemical journal, Vol. 351 Pt 2, Issue 2, pp. 289-305, 2001 (PubMed).

Johnson, Lapadat: "Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases." in: Science (New York, N.Y.), Vol. 298, Issue 5600, pp. 1911-2, 2002 (PubMed).

Smalley: "A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?" in: International journal of cancer. Journal international du cancer, Vol. 104, Issue 5, pp. 527-32, 2003 (PubMed).

Koleganova, Piecha, Ritz et al.: "Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats." in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 24, Issue 3, pp. 778-87, 2009 (PubMed).

Alternatives for antigen "ERK1 / ERK2", type "Antibodies"
Hosts (103), (23), (4)
Reactivities (123), (65), (63), (44), (40), (36), (24), (12), (7), (4), (4), (1), (1)
Applications (95), (36), (30), (29), (25), (19), (15), (12), (6), (6), (2)
Conjugates (7), (7), (3), (3), (3), (3), (3), (3), (3), (3), (3)
Epitopes (45), (42), (20), (18), (12), (12), (5), (4), (4), (4), (3), (2), (2), (2), (1), (1), (1), (1), (1), (1)